Preview

Current Pediatrics

Advanced search

ASTHMA AND VIRAL INFECTIONS IN CHILDREN

https://doi.org/10.15690/vsp.v13i1.922

Abstract

Viruses are the most common pathogens of acute respiratory diseases — most often causing mild symptoms of common cold: cough, runny nose, temperature increases. At the same time, 1/3 of children have the following symptoms of lower respiratory tract disorders: shortness of breath, wheezing, coughing, respiratory failure. Virus-induced wheezing are risk factors for development of asthma in childhood. Recent clinical and scientific data suggest: the more difficult are viral respiratory infections in young children, the higher their risk of asthma later on. Another feature is that children with allergic diseases are much more likely to have viral respiratory infections
(and with longer clinical course), compared with children without atopy. The use of ibuprofen is safe for children over 3 months, including suffering from bronchial asthma.

About the Author

D. Sh. Macharadze
People’s Friendship University of Russia, Moscow
Russian Federation
PhD, professor of the Department of Allergology and Immunopathology of PFUR


References

1. Tregoning, J., Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 2010; 23: 74–98.

2. Inoue Y., Shimojo N. Epidemiology of virus-induced wheezing/asthma in children. Front. Microbiol. 2013; 4: 391.

3. Nicholson K., Kent J., Ireland D. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993; 307 (6910): 982–9986.

4. Grissell T., Powell H., Shafren D., Boyle M., Hensley M., Jones P., Whitehead B., Gibson P. Interleukin-10 gene expression in acute virus-induced asthma. Am. J. Respir. Crit Care Med. 2005; 172 (4): 433–439.

5. Nafstad P., Bert B., Skrondal A., Nystad Р. Еarly Respiratory Infections, Asthma, and Allergy: 10-Year Follow-up of the Oslo Birth Cohort. Pediatrics. 2005; 116: 255–262.

6. Papadopoulos N., Xepapadaki P., Mallia P., Brusselle G., Watelet J. B., Xatzipsalti M., Foteinos G., van Drunen C. M., Fok kens W. J., D'Ambrosio C., Bonini S., Bossios A., Lztvall J., van Cauwen berge P., Holgate S. T., Canonica G. W., Szczeklik A., Rohde G., Kimpen J., Pitkdranta A., Makela M., Chanez P., Ring J., Johns ton S. L. Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2 LEN and InterAirways document. Allergy. 2007; 62: 457–470.

7. Jackson D., Evans M., Gangnon R., Tisler C., Pappas T., Lee W., Gern J., Lemanske R., Jr. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am. J. Respir. Crit. Care Med. 2012; 185: 281–285.

8. Papadopoulos N., Stanciu L., Papi A., Holgate S., Johnston S. A defective type 1 response to rhinovirus in atopic asthma. Thorax. 2002; 57: 328–332.

9. Kuehni C., Spycher B., Silverman M. Causal links between RSV infection and asthma: no clear answers to an old question. Am. J. Respir. Crit. Care Med. 2009; 179: 1079–1080.

10. Sigurs N., Aljassim F., Kjellman B., Robinson P.D., Sigurbergsson F., Bjarnason R. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010; 65: 1045–1052.

11. Simoes E. A., Carbonell-Estrany X., Rieger C. H., Mitchell I., Fredrick L., Groothuis J. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J. Allergy Clin. Immunol. 2010; 126: 256–262.

12. Jackson D., Gangnon R., Evans M., Roberg K., Anderson E., Pappas T.E. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med. 2008; 178: 667–672.

13. Williams J., Tollefson S., Heymann P., Carper H., Patrie J., Crowe J. Human metapneumovirus infection in children hospitalized for wheezing. J. Allergy Clin. Immunol. 2005; 115: 1311–1312.

14. Hasegawa S., Hirano R., Hashimoto K., Haneda Y., Shirabe K., Ichiyama T. Characteristics of atopic children with pandemic H1N1 influenza viral infection: pandemic H1N1 influenza reveals ‘occult’ asthma of childhood. Pediatr. Allergy Immunol. 2011; 22: 119–123.

15. Kusel M., Kebadze T., Johnston S., Holt P., Sly P. Febrile respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze. Eur. Respir. J. 2012; 39: 876–882.

16. Sullivan J., Farrar H. Fever and Antipyretic Use in Children. Pediatrics. 2011; 127: 580–587.

17. Mahar A.F., Allen S.J., Milligan P., Suthumnirund S., Chotpitayasunondh T., Sabchareon A., Coulter J.B.S. Tepid sponging to reduce temperature in febrile children in a tropical climate. Clin. Pediatr. (Phila). 1994; 33: 227–231.

18. Kader A., Hildebrandt T., Powell C. How safe is ibuprofen in febrile asthmatic children? Arch. Dis. Child. 2004; 89: 885–886.

19. Martinez-Gimeno A., Garcнa-Marcos L. The association between acetaminophen and asthma. Should its pediatric use be banned? Exp. Rev. Resp. Med. 2013; 7 (2): 113–122.

20. Dimova S., Hoet P., Dinsdale D, Nemery B. Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. Int. J. Biochem. Cell Biol. 2005; 37: 1727–1737.

21. Beasley R., Clayton T., Crane J. ISAAC Phase Three Study Group. Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three. Am. J. Respir. Crit. Care Med. 2011; 183: 171–178.

22. Beasley R., Clayton T., Crane J., von Mutius E., Lai C.K., Montefort S., Stewart A.; ISAAC Phase Three Study Group. Collaborators (96). Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme. Lancet. 2008; 372: 1039-1048.

23. McIntyre J., Hull D. Comparing efficacy and tolerability of ibuprofen and paracetamol in fever. Arch. Dis. Child. 1996; 72: 164–167.

24. Balabolkin I.I., Macharadze D.Sh. Aspirin-induced asthma in children. Allergologiya = Allergology. 1999; 4: 29–31.

25. Macharadze D.Sh. Aspirin and asthma: pediatric aspects. Lechashchii vrach = The attending physician. 2004; 3: 42–45.

26. Koschel D., Weber N., Hiffken G. Tolerability to etoricoxib in patients with aspirin-exacerbated respiratory disease. J. Investig. Allergol. Clin. Immunol. 2013; 23: 275–280.

27. Macharadze D.Sh. Viruses and asthma: more questions than answers. Lechashchii vrach = The attending physician. 2009; 10: 73–76.


Review

For citations:


Macharadze D.Sh. ASTHMA AND VIRAL INFECTIONS IN CHILDREN. Current Pediatrics. 2014;13(1):124-128. (In Russ.) https://doi.org/10.15690/vsp.v13i1.922

Views: 903


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)